Literature DB >> 27009167

Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.

Landon W Locke1, Michael M Myerburg1, Daniel J Weiner2, Matthew R Markovetz3, Robert S Parker4, Ashok Muthukrishnan5, Lawrence Weber5, Michael R Czachowski6, Ryan T Lacy7, Joseph M Pilewski8, Timothy E Corcoran9.   

Abstract

Airway surface liquid hyperabsorption and mucus accumulation are key elements of cystic fibrosis lung disease that can be assessed in vivo using functional imaging methods. In this study we evaluated experimental factors affecting measurements of mucociliary clearance (MCC) and small-molecule absorption (ABS) and patient factors associated with abnormal absorption and mucus clearance.Our imaging technique utilises two radiopharmaceutical probes delivered by inhalation. Measurement repeatability was assessed in 10 adult cystic fibrosis subjects. Experimental factors were assessed in 29 adult and paediatric cystic fibrosis subjects (51 scans). Patient factors were assessed in a subgroup with optimal aerosol deposition (37 scans; 24 subjects). Paediatric subjects (n=9) underwent initial and 2-year follow-up scans. Control subjects from a previously reported study are included for comparison.High rates of central aerosol deposition influenced measurements of ABS and, to a lesser extent, MCC. Depressed MCC in cystic fibrosis was only detectable in subjects with previous Pseudomonas aeruginosa infection. Cystic fibrosis subjects without P. aeruginosa had similar MCC to control subjects. Cystic fibrosis subjects had consistently higher ABS rates.We conclude that the primary experimental factor affecting MCC/ABS measurements is central deposition percentage. Depressed MCC in cystic fibrosis is associated with P. aeruginosa infection. ABS is consistently increased in cystic fibrosis.
Copyright ©ERS 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27009167      PMCID: PMC5516211          DOI: 10.1183/13993003.01880-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Multisite comparison of mucociliary and cough clearance measures using standardized methods.

Authors:  William D Bennett; Beth L Laube; Timothy Corcoran; Kirby Zeman; Gail Sharpless; Kristina Thomas; Jihong Wu; Peter J Mogayzel; Joseph Pilewski; Scott Donaldson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-03-21       Impact factor: 2.849

2.  The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.

Authors:  M Robinson; E Daviskas; S Eberl; J Baker; H K Chan; S D Anderson; P T Bye
Journal:  Eur Respir J       Date:  1999-09       Impact factor: 16.671

3.  Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

Authors:  Scott H Donaldson; William D Bennett; Kirby L Zeman; Michael R Knowles; Robert Tarran; Richard C Boucher
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

4.  Effects of upper respiratory tract infections in patients with cystic fibrosis.

Authors:  J Collinson; K G Nicholson; E Cancio; J Ashman; D C Ireland; V Hammersley; J Kent; C O'Callaghan
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

5.  Quantitative deposition of aerosolized gentamicin in cystic fibrosis.

Authors:  J S Ilowite; J D Gorvoy; G C Smaldone
Journal:  Am Rev Respir Dis       Date:  1987-12

6.  Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway.

Authors:  T E Corcoran; K M Thomas; M M Myerburg; A Muthukrishnan; L Weber; R Frizzell; J M Pilewski
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

7.  Quantitative imaging of airway liquid absorption in cystic fibrosis.

Authors:  Landon W Locke; Michael M Myerburg; Matthew R Markovetz; Robert S Parker; Lawrence Weber; Michael R Czachowski; Thomas J Harding; Stefanie L Brown; Joseph A Nero; Joseph M Pilewski; Timothy E Corcoran
Journal:  Eur Respir J       Date:  2014-04-17       Impact factor: 16.671

Review 8.  Mucociliary clearance as an outcome measure for cystic fibrosis clinical research.

Authors:  Scott H Donaldson; Timothy E Corcoran; Beth L Laube; William D Bennett
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

9.  Effect of bacterial products on human ciliary function in vitro.

Authors:  R Wilson; D Roberts; P Cole
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

10.  A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.

Authors:  Matthew R Markovetz; Timothy E Corcoran; Landon W Locke; Michael M Myerburg; Joseph M Pilewski; Robert S Parker
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

View more
  10 in total

1.  Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect.

Authors:  Timothy E Corcoran; Alex S Huber; Michael M Myerburg; Daniel J Weiner; Landon W Locke; Ryan T Lacy; Lawrence Weber; Michael R Czachowski; Darragh J Johnston; Ashok Muthukrishnan; Alison T Lennox; Joseph M Pilewski
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-04-10       Impact factor: 2.849

2.  Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR.

Authors:  Scott H Donaldson; Beth L Laube; Timothy E Corcoran; Pradeep Bhambhvani; Kirby Zeman; Agathe Ceppe; Pamela L Zeitlin; Peter J Mogayzel; Michael Boyle; Landon W Locke; Michael M Myerburg; Joseph M Pilewski; Brian Flanagan; Steven M Rowe; William D Bennett
Journal:  JCI Insight       Date:  2018-12-20

3.  The putative bacterial oxygen sensor Pseudomonas prolyl hydroxylase (PPHD) suppresses antibiotic resistance and pathogenicity in Pseudomonas aeruginosa.

Authors:  Bettina Schaible; Bianca Crifo; Kirsten Schaffer; Cormac T Taylor
Journal:  J Biol Chem       Date:  2019-12-11       Impact factor: 5.157

4.  A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia.

Authors:  Florencio Serrano Castillo; Carol A Bertrand; Michael M Myerburg; Monica E Shapiro; Timothy E Corcoran; Robert S Parker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-09-07       Impact factor: 2.745

5.  Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation.

Authors:  Timothy E Corcoran; Alex S Huber; Sherri L Hill; Landon W Locke; Lawrence Weber; Ashok Muthukrishnan; Elisa M Heidrich; Sally Wenzel; Mike M Myerburg
Journal:  Chest       Date:  2021-05-21       Impact factor: 9.410

6.  β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections.

Authors:  Heike Grassmé; Brian Henry; Regan Ziobro; Katrin Anne Becker; Joachim Riethmüller; Aaron Gardner; Aaron P Seitz; Joerg Steinmann; Stephan Lang; Christopher Ward; Edward H Schuchman; Charles C Caldwell; Markus Kamler; Michael J Edwards; Malcolm Brodlie; Erich Gulbins
Journal:  Cell Host Microbe       Date:  2017-05-25       Impact factor: 21.023

7.  Viscoelastic properties of Pseudomonas aeruginosa variant biofilms.

Authors:  Erin S Gloag; Guy K German; Paul Stoodley; Daniel J Wozniak
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.996

8.  Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections.

Authors:  Katrin Anne Becker; Rabea Verhaegh; Hedda-Luise Verhasselt; Simone Keitsch; Matthias Soddemann; Barbara Wilker; Gregory C Wilson; Jan Buer; Syed A Ahmad; Michael J Edwards; Erich Gulbins
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 9.  Mucus Clearance Strategies in Mechanically Ventilated Patients.

Authors:  Ryan L Goetz; Kadambari Vijaykumar; George M Solomon
Journal:  Front Physiol       Date:  2022-03-23       Impact factor: 4.566

10.  Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa.

Authors:  Jan C Thomassen; Tobias Trojan; Maxine Walz; Christina Vohlen; Gregor Fink; Ernst Rietschel; Miguel A Alejandre Alcazar; Silke van Koningsbruggen-Rietschel
Journal:  ERJ Open Res       Date:  2021-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.